Epinephrine Autoinjector Market Share

Statistics for the 2023 & 2024 Epinephrine Autoinjector market share, created by Mordor Intelligence™ Industry Reports. Epinephrine Autoinjector share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Epinephrine Autoinjector Industry

The epinephrine autoinjector market is consolidated in nature with the presence of a few established vendors holding the majority of the shares and operating globally. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well known, including Adamis Pharmaceuticals Corporation, Alk-Abello A/S, Amneal Pharmaceuticals, Mylan NV, Antares Pharma, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Bausch & Lomb Incorporated, Sanofi SA, Novartis International AG, among others.

Epinephrine Autoinjector Market Leaders

  1. ALK-Abelló A/S

  2. Amneal Pharmaceuticals, Inc.

  3. Antares Pharma, Inc.

  4. Pfizer Inc.

  5. Teva Pharmaceutical Industries Ltd.

*Disclaimer: Major Players sorted in no particular order

Epinephrine Autoinjector Market Concentration

Epinephrine Autoinjector Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)